phosphotyrosines

Phosphotyrosine refers to a tyrosine residue in a protein that has been modified by the covalent attachment of a phosphate group to its phenolic hydroxyl. The modification, produced by protein tyrosine kinases, introduces a negatively charged phosphate moiety that commonly alters protein conformation and creates a binding site for signaling proteins. Tyrosine phosphorylation is dynamically balanced by protein tyrosine phosphatases, enabling rapid on/off control of signaling states.

Phosphotyrosines play central roles in many cellular signaling pathways. Receptor tyrosine kinases (RTKs) and non-receptor tyrosine kinases phosphorylate substrates on tyrosine residues, generating phosphotyrosine docking sites for SH2-domain and PTB-domain containing proteins. This recruitment propagates cascades such as the MAPK, PI3K-Akt, and JAK-STAT pathways, linking extracellular cues to gene expression, metabolism, and cell fate decisions.

Detection and study of phosphotyrosines rely on methods such as anti-phosphotyrosine antibodies for Western blotting and immunoprecipitation, and phosphoproteomics by mass spectrometry to map phosphorylation sites across the proteome. The presence and pattern of phosphotyrosines depend on cellular context, stimuli, and disease state.

Motifs and specificity: SH2 domains recognize phosphotyrosine-containing motifs in target proteins; the surrounding amino acids influence binding affinity and site selectivity.

Clinical relevance: Abnormal tyrosine phosphorylation is implicated in cancers and other diseases; tyrosine kinase inhibitors, such as imatinib and erlotinib, are used therapeutically to modulate aberrant signaling.